These GE11-VLPs-MEG3 could pass through the cell membrane in an EGFR-dependent manner and acted as tumor suppressors against HCC in vivo and in vitro, via a p53-related signaling pathway (Figure 9). This evidence concerns the gene EGFR and hepatocellular carcinoma.